MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Stryker Corporation Total Assets 2011-2026 | SYK
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.8 B | 43 B | 39.9 B | 36.9 B | 34.6 B | 34.3 B | 30.2 B | 27.2 B | 22.2 B | 20.4 B | 16.2 B | 17.7 B | 15.7 B | 13.2 B | 12.4 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47.8 B | 12.4 B | 27.5 B |
Quarterly Total Assets Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47.1 B | 46.3 B | 46 B | 43.8 B | 39.1 B | 39.4 B | 38 B | 37.4 B | 36.8 B | 36.9 B | 36 B | - | 36.1 B | 34.6 B | 34.1 B | 33.7 B | 33.5 B | 34.3 B | 34.3 B | 34.3 B | 34.3 B | 30.2 B | 30.2 B | 30.2 B | 30.2 B | 27.2 B | 27.2 B | 27.2 B | 27.2 B | 22.2 B | 22.2 B | 22.2 B | 22.2 B | 20.4 B | 20.4 B | 20.4 B | 20.4 B | 16.2 B | 16.2 B | 16.2 B | 16.2 B | 17.3 B | 17.7 B | 17.7 B | 17.7 B | 15.4 B | 15.7 B | 15.7 B | 15.7 B | 13.2 B | 13.2 B | 13.2 B | 13.2 B | 12.1 B | 12.4 B | 12.4 B | 12.4 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 47.1 B | 12.1 B | 26 B |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AxoGen
AXGN
|
222 M | $ 32.5 | -8.14 % | $ 1.44 B |  USA |
 |
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
43.4 M | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
791 M | $ 13.77 | 4.86 % | $ 1.97 B | USA |
 |
Bio-Rad Laboratories
BIO
|
9.36 B | $ 269.87 | 0.53 % | $ 7.61 B | USA |
 |
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
79.2 M | $ 3.53 | -1.12 % | $ 122 M | USA |
 |
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
39.2 M | $ 14.58 | -1.22 % | $ 394 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
498 M | $ 6.36 | 0.32 % | $ 457 M |  Israel |
 |
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
5.81 B | $ 39.87 | 0.77 % | $ 5.94 K | USA |
 |
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 75.27 | 1.21 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
86.1 M | $ 4.52 | - | $ 169 M |  France |
 |
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
15.4 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
53.8 M | $ 23.17 | -5.16 % | $ 196 M | USA |
 |
CONMED Corporation
CNMD
|
2.33 B | $ 46.0 | 1.39 % | $ 1.43 B | USA |
 |
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M |  Canada |
 |
GBS
GBS
|
8.25 M | - | -0.57 % | $ 7.12 M | USA |
 |
Cutera
CUTR
|
346 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
76.6 M | $ 9.94 | 2.0 % | $ 283 M | USA |
 |
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
132 M | - | - | $ 10.2 M | USA |
 |
InMode Ltd.
INMD
|
766 M | $ 14.0 | -1.41 % | $ 905 M | Israel |
 |
Establishment Labs Holdings
ESTA
|
347 M | $ 78.78 | 5.1 % | $ 2.22 B |  Costa-rica |
 |
IRadimed Corporation
IRMD
|
98.3 M | $ 99.04 | -2.22 % | $ 1.25 B | USA |
 |
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | USA |
 |
FONAR Corporation
FONR
|
199 M | $ 18.55 | -0.22 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
5.3 B | $ 92.25 | -1.25 % | $ 12.5 B | USA |
 |
LivaNova PLC
LIVN
|
2.51 B | $ 69.26 | 1.32 % | $ 3.76 B |  Britain |
 |
Pulmonx Corporation
LUNG
|
163 M | $ 1.51 | 2.03 % | $ 59.1 M | USA |
 |
Helius Medical Technologies
HSDT
|
7.69 M | $ 1.88 | - | $ 1.14 M | USA |
 |
Medtronic PLC
MDT
|
91.7 B | $ 97.06 | -1.57 % | $ 125 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
4.04 B | $ 11.57 | -1.66 % | $ 891 M | USA |
 |
MiMedx Group
MDXG
|
264 M | $ 5.35 | 0.28 % | $ 786 M | USA |